share_log

Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays

Dow Jones Newswires ·  Feb 18, 2021 22:57

DJ Blueprint Medicines Is Maintained at Equal-Weight by Barclays

Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings

(END) Dow Jones Newswires

February 18, 2021 09:57 ET (14:57 GMT)

DJ Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays

Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings

(END) Dow Jones Newswires

February 18, 2021 09:57 ET (14:57 GMT)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment